The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antibody Fragments-Global Market Insights and Sales Trends 2025
Synopsis
The global Antibody Fragments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antibody Fragments in various end use industries. The expanding demands from the Cancer, Immunodeficiencies and Other, are propelling Antibody Fragments market. F(ab) Fragment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the F(ab’)2 Fragment segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibody Fragments market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibody Fragments market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibody Fragments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibody Fragments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibody Fragments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibody Fragments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibody Fragments covered in this report include Novartis, F. Hoffmann-La Roche, Johnson & Johnson, Amgen, Bristol-Myers Squibb, AbbVie, Takeda Pharmaceutical, Sanofi and Biogen, etc.
The global Antibody Fragments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
F. Hoffmann-La Roche
Johnson & Johnson
Amgen
Bristol-Myers Squibb
AbbVie
Takeda Pharmaceutical
Sanofi
Biogen
Eli Lilly
Global Antibody Fragments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibody Fragments market, Segment by Type:
F(ab) Fragment
F(ab’)2 Fragment
Global Antibody Fragments market, by Application
Cancer
Immunodeficiencies
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antibody Fragments manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antibody Fragments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Antibody Fragments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antibody Fragments in various end use industries. The expanding demands from the Cancer, Immunodeficiencies and Other, are propelling Antibody Fragments market. F(ab) Fragment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the F(ab’)2 Fragment segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibody Fragments market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibody Fragments market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibody Fragments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibody Fragments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibody Fragments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibody Fragments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibody Fragments covered in this report include Novartis, F. Hoffmann-La Roche, Johnson & Johnson, Amgen, Bristol-Myers Squibb, AbbVie, Takeda Pharmaceutical, Sanofi and Biogen, etc.
The global Antibody Fragments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
F. Hoffmann-La Roche
Johnson & Johnson
Amgen
Bristol-Myers Squibb
AbbVie
Takeda Pharmaceutical
Sanofi
Biogen
Eli Lilly
Global Antibody Fragments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibody Fragments market, Segment by Type:
F(ab) Fragment
F(ab’)2 Fragment
Global Antibody Fragments market, by Application
Cancer
Immunodeficiencies
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antibody Fragments manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antibody Fragments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antibody Fragments Market Overview
1.1 Antibody Fragments Product Overview
1.2 Antibody Fragments Market Segment by Type
1.2.1 F(ab) Fragment
1.2.2 F(ab’)2 Fragment
1.3 Global Antibody Fragments Market Size by Type
1.3.1 Global Antibody Fragments Market Size Overview by Type (2018-2029)
1.3.2 Global Antibody Fragments Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antibody Fragments Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody Fragments Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antibody Fragments Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antibody Fragments Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antibody Fragments Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antibody Fragments Sales Breakdown by Type (2018-2023)
2 Global Antibody Fragments Market Competition by Company
2.1 Global Top Players by Antibody Fragments Sales (2018-2023)
2.2 Global Top Players by Antibody Fragments Revenue (2018-2023)
2.3 Global Top Players by Antibody Fragments Price (2018-2023)
2.4 Global Top Manufacturers Antibody Fragments Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody Fragments Market Competitive Situation and Trends
2.5.1 Antibody Fragments Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody Fragments Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Fragments as of 2022)
2.7 Date of Key Manufacturers Enter into Antibody Fragments Market
2.8 Key Manufacturers Antibody Fragments Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antibody Fragments Status and Outlook by Region
3.1 Global Antibody Fragments Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antibody Fragments Historic Market Size by Region
3.2.1 Global Antibody Fragments Sales in Volume by Region (2018-2023)
3.2.2 Global Antibody Fragments Sales in Value by Region (2018-2023)
3.2.3 Global Antibody Fragments Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antibody Fragments Forecasted Market Size by Region
3.3.1 Global Antibody Fragments Sales in Volume by Region (2024-2029)
3.3.2 Global Antibody Fragments Sales in Value by Region (2024-2029)
3.3.3 Global Antibody Fragments Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antibody Fragments by Application
4.1 Antibody Fragments Market Segment by Application
4.1.1 Cancer
4.1.2 Immunodeficiencies
4.1.3 Other
4.2 Global Antibody Fragments Market Size by Application
4.2.1 Global Antibody Fragments Market Size Overview by Application (2018-2029)
4.2.2 Global Antibody Fragments Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antibody Fragments Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibody Fragments Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antibody Fragments Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antibody Fragments Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antibody Fragments Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antibody Fragments Sales Breakdown by Application (2018-2023)
5 North America Antibody Fragments by Country
5.1 North America Antibody Fragments Historic Market Size by Country
5.1.1 North America Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antibody Fragments Sales in Volume by Country (2018-2023)
5.1.3 North America Antibody Fragments Sales in Value by Country (2018-2023)
5.2 North America Antibody Fragments Forecasted Market Size by Country
5.2.1 North America Antibody Fragments Sales in Volume by Country (2024-2029)
5.2.2 North America Antibody Fragments Sales in Value by Country (2024-2029)
6 Europe Antibody Fragments by Country
6.1 Europe Antibody Fragments Historic Market Size by Country
6.1.1 Europe Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antibody Fragments Sales in Volume by Country (2018-2023)
6.1.3 Europe Antibody Fragments Sales in Value by Country (2018-2023)
6.2 Europe Antibody Fragments Forecasted Market Size by Country
6.2.1 Europe Antibody Fragments Sales in Volume by Country (2024-2029)
6.2.2 Europe Antibody Fragments Sales in Value by Country (2024-2029)
7 Asia-Pacific Antibody Fragments by Region
7.1 Asia-Pacific Antibody Fragments Historic Market Size by Region
7.1.1 Asia-Pacific Antibody Fragments Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antibody Fragments Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antibody Fragments Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antibody Fragments Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibody Fragments Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antibody Fragments Sales in Value by Region (2024-2029)
8 Latin America Antibody Fragments by Country
8.1 Latin America Antibody Fragments Historic Market Size by Country
8.1.1 Latin America Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antibody Fragments Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antibody Fragments Sales in Value by Country (2018-2023)
8.2 Latin America Antibody Fragments Forecasted Market Size by Country
8.2.1 Latin America Antibody Fragments Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antibody Fragments Sales in Value by Country (2024-2029)
9 Middle East and Africa Antibody Fragments by Country
9.1 Middle East and Africa Antibody Fragments Historic Market Size by Country
9.1.1 Middle East and Africa Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antibody Fragments Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antibody Fragments Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antibody Fragments Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody Fragments Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antibody Fragments Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Antibody Fragments Products Offered
10.1.5 Novartis Recent Development
10.2 F. Hoffmann-La Roche
10.2.1 F. Hoffmann-La Roche Company Information
10.2.2 F. Hoffmann-La Roche Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.2.4 F. Hoffmann-La Roche Antibody Fragments Products Offered
10.2.5 F. Hoffmann-La Roche Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson & Johnson Antibody Fragments Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Amgen
10.4.1 Amgen Company Information
10.4.2 Amgen Introduction and Business Overview
10.4.3 Amgen Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Amgen Antibody Fragments Products Offered
10.4.5 Amgen Recent Development
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Company Information
10.5.2 Bristol-Myers Squibb Introduction and Business Overview
10.5.3 Bristol-Myers Squibb Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bristol-Myers Squibb Antibody Fragments Products Offered
10.5.5 Bristol-Myers Squibb Recent Development
10.6 AbbVie
10.6.1 AbbVie Company Information
10.6.2 AbbVie Introduction and Business Overview
10.6.3 AbbVie Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AbbVie Antibody Fragments Products Offered
10.6.5 AbbVie Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Information
10.7.2 Takeda Pharmaceutical Introduction and Business Overview
10.7.3 Takeda Pharmaceutical Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Takeda Pharmaceutical Antibody Fragments Products Offered
10.7.5 Takeda Pharmaceutical Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Antibody Fragments Products Offered
10.8.5 Sanofi Recent Development
10.9 Biogen
10.9.1 Biogen Company Information
10.9.2 Biogen Introduction and Business Overview
10.9.3 Biogen Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Biogen Antibody Fragments Products Offered
10.9.5 Biogen Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Information
10.10.2 Eli Lilly Introduction and Business Overview
10.10.3 Eli Lilly Antibody Fragments Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Eli Lilly Antibody Fragments Products Offered
10.10.5 Eli Lilly Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody Fragments Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody Fragments Industrial Chain Analysis
11.4 Antibody Fragments Market Dynamics
11.4.1 Antibody Fragments Industry Trends
11.4.2 Antibody Fragments Market Drivers
11.4.3 Antibody Fragments Market Challenges
11.4.4 Antibody Fragments Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody Fragments Distributors
12.3 Antibody Fragments Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
